Abstract
Arrhythmogenic cardiomyopathy is a hereditary disease characterized by the replacement
of the myocardium by fibrofatty tissue. In recent years, three patterns have been
described: the classic right variant, the biventricular variant, and the variant with
predominant involvement of the left ventricle. Nowadays, cardiac magnetic resonance
is a fundamental tool for diagnosis of arrhythmogenic left ventricular cardiomyopathy.
Late gadolinium enhancement is a very sensitive indicator of early left-sided involvement,
and is included as a marker in the current arrhythmogenic cardiomyopathy criteria.
We report a case of arrhythmogenic left ventricular cardiomyopathy with atypical form
of presentation as recurrent myocarditis. Clinical suspicion was important for the
diagnosis, as the patient did not present data that would point to an infectious origin
of the disease. However, the key to diagnosis was detecting a characteristic imaging
pattern on cardiac magnetic resonance. Initially, a meso-subepicardial fibrosis located
in lateral wall was observed, which progressively spread to other regions until it
became practically global. In addition, irregularities were observed in the epicardial
contour that were suggestive of fatty infiltration, all consistent with the diagnosis
of arrhythmogenic left ventricular cardiomyopathy.
Learning objective
Arrhythmogenic left ventricular cardiomyopathy has recently been recognized as part
of the arrhythmogenic cardiomyopathy spectrum. Given the difficulties in its diagnosis,
it is essential to have a high index of suspicion. We must pay attention to the clinical
context and the cardiac magnetic resonance imaging findings, which has become an essential
imaging tool for diagnosis.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiology CasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Arrhythmogenic cardiomyopathy.Orphanet J Rare Dis. 2016; 11 (PMID: 27038780; PMCID: PMC4818879): 33https://doi.org/10.1186/s13023-016-0407-1
- Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.Circulation. 2007; 115 (Epub 2007 Mar 19 PMID: 17372169): 1710-1720https://doi.org/10.1161/CIRCULATIONAHA.106.660241
- Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.J Am Coll Cardiol. 2008; 52 (PMID: 19095136): 2175-2187https://doi.org/10.1016/j.jacc.2008.09.019
- Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria.Int J Cardiol. 2020; 319 (Epub 2020 Jun 16 PMID: 32561223): 106-114https://doi.org/10.1016/j.ijcard.2020.06.005
- Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy.Rev Esp Cardiol (Engl Ed). 2020; 73 (English, Spanish) (Epub 2020 Jan 25. PMID: 31992505): 885-892https://doi.org/10.1016/j.rec.2019.12.004
Article info
Publication history
Published online: December 31, 2022
Accepted:
November 30,
2022
Received in revised form:
November 14,
2022
Received:
September 30,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.